Consensus $2.49. The company said, “Baxter (BAX) now expects sales growth from continuing operations of 7% to 8% on a reported basis. On an operational basis, Baxter expects sales growth of 4% to 5%. The company now expects adjusted earnings from continuing operations, before special items, of $2.47 to $2.55 per diluted share, compared to prior guidance of $2.45 to $2.55 per diluted share.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter call volume above normal and directionally bullish
- Is BAX a Buy, Before Earnings?
- Baxter participates in a conference call with JPMorgan
- Baxter International: Navigating Leadership Transition and Market Growth Amidst Tariff Challenges
- Baxter International Appoints New Leadership Amid Strategic Changes